Choriogonadotropin Alfa Patent Expiration

Choriogonadotropin Alfa was first introduced by Emd Serono Inc in its drug Ovidrel on Sep 20, 2000.


Choriogonadotropin Alfa Patents

Given below is the list of patents protecting Choriogonadotropin Alfa, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ovidrel US5767251 Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof Jun 16, 2015

(Expired)

Emd Serono
Ovidrel US6706681 HCG liquid formulations Mar 16, 2021

(Expired)

Emd Serono


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳